ArticleBMC cancer2013

Treatment with a combination of the ErbB (HER) family blocker afatinib and the IGF-IR inhibitor, NVP-AEW541 induces synergistic growth inhibition of human pancreatic cancer cells.

Nikolaos Ioannou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.